The amino acid l-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice

RationaleThe cognitive and attentional deficits observed in schizophrenic patients are now considered central to the pathophysiology of the disorder. These deficits include an inability to filter sensory input as measured by, e.g., prepulse inhibition (PPI) reflex. Administration of phencyclidine (PCP), a drug that can induce a schizophrenia-like psychosis in humans, disrupts PPI in experimental animals. In rodents, this PCP-induced deficit can be blocked by pretreatment with nitric oxide (NO) synthase inhibitors. This suggests that some of the behavioral effects of PCP are mediated via NO. The substrate for in vivo NO production is l-arginine, and active transport of l-arginine via the cationic amino acid transporter may serve as a regulatory mechanism in NO production.ObjectivesThe aim of the present study was to study the effects of l-arginine transport inhibition, using acute and repeated l-lysine treatment, on PCP-induced disruption of PPI in mice.ResultsSubchronic, and to some extent acute, pretreatment with l-lysine blocked a PCP-induced deficit in PPI without affecting basal PPI.Conclusionsl-lysine has been shown to block l-arginine transport in vitro, most likely via a competitive blockade and down regulation of cationic amino acid transporters. However, the importance of l-arginine transport as a regulatory mechanism in NO production in vivo is still not clear. The present results lend further support to the notion that some of the effects of PCP in the central nervous system are mediated via NO and that l-arginine transport may play a role in the regulation of NO production in the brain.

[1]  H. Christensen,et al.  Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts. , 1982, The Journal of biological chemistry.

[2]  H. Hoffman,et al.  Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. , 1980, Psychological review.

[3]  Guoyao Wu,et al.  Arginine metabolism: nitric oxide and beyond. , 1998, The Biochemical journal.

[4]  G. Hongping,et al.  Neuroprotective effect of L-lysine monohydrochloride on acute iterative anoxia in rats with quantitative analysis of electrocorticogram. , 1999, Life sciences.

[5]  J. Garthwaite,et al.  NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. , 1989, European journal of pharmacology.

[6]  David L. Braff,et al.  Information-processing deficits and thought disorder in schizophrenia. , 1994 .

[7]  G. Wu,et al.  Arginine nutrition and cardiovascular function. , 2000, The Journal of nutrition.

[8]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[9]  H. Wiesinger.  Arginine metabolism and the synthesis of nitric oxide in the nervous system , 2001, Progress in Neurobiology.

[10]  D. Jackson,et al.  The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effects when given alone. , 1999, Pharmacology & toxicology.

[11]  P. Rosenberg,et al.  Methylene blue adjuvant therapy of schizophrenia. , 1997, Clinical neuropharmacology.

[12]  D. Jackson,et al.  Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat , 1997, Psychopharmacology.

[13]  J. Wiley.  Nitric Oxide Synthase Inhibitors Attenuate Phencyclidine-Induced Disruption of Prepulse Inhibition , 1998, Neuropsychopharmacology.

[14]  N. Swerdlow,et al.  Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. , 1999, The American journal of psychiatry.

[15]  Jörgen A. Engel,et al.  Effects of phencyclidine on acoustic startle and prepulse inhibition in neuronal nitric oxide synthase deficient mice , 2005, European Neuropsychopharmacology.

[16]  Jörgen A. Engel,et al.  The nitric oxide synthase inhibitor. L-NAME, blocks certain phencyclidine-induced but not amphetamine-induced effects on behaviour and brain biochemistry in the rat , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[18]  L. Nelin,et al.  l-Lysine Decreases Nitric Oxide Production and Increases Vascular Resistance in Lungs Isolated from Lipopolysaccharide-Treated Neonatal Pigs , 2004, Pediatric Research.

[19]  S. Snyder,et al.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Bernhard Bogerts,et al.  The many faces of nitric oxide in schizophrenia. A review , 2005, Schizophrenia Research.

[21]  E. Closs,et al.  Plasma membrane transporters for arginine. , 2004, The Journal of nutrition.

[22]  D. Harrison,et al.  Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. , 1995, The Journal of clinical investigation.

[23]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[24]  D. Braff.  Information processing and attention dysfunctions in schizophrenia. , 1993, Schizophrenia bulletin.

[25]  U. Förstermann,et al.  Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. , 2000, Molecular pharmacology.

[26]  J. Engel,et al.  Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition , 2005, Psychopharmacology.

[27]  H. Wright,et al.  Phencyclidine-induced psychosis. , 1980, Southern medical journal.

[28]  E. Block,et al.  A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”* , 1997, The Journal of Biological Chemistry.

[29]  U. Förstermann,et al.  Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. , 1997, Nitric oxide : biology and chemistry.

[30]  J. Hibbs,et al.  L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. , 1987, Journal of immunology.

[31]  K. Torii,et al.  Prolonged Treatment with l-Lysine and l-Arginine Reduces Stress-induced Anxiety in an Elevated Plus Maze , 2003, Nutritional neuroscience.

[32]  T. Archer,et al.  Antagonism of the nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning , 2005, Behavioural Brain Research.

[33]  J. Engel,et al.  Phencyclidine-induced behaviour in mice prevented by methylene blue. , 2004, Basic & clinical pharmacology & toxicology.

[34]  J. Engel,et al.  The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. , 2004, European journal of pharmacology.

[35]  S. Deutsch,et al.  Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice. , 1997, Clinical neuropharmacology.

[36]  Jörgen A. Engel,et al.  Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms , 2004, Psychopharmacology.

[37]  A. Brading,et al.  The effects of exogenous amino acids on the relaxant responses of pig urethral smooth muscle evoked by stimulation of the inhibitory nitrergic nerves , 2004, Pflügers Archiv.

[38]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[39]  J. Viña,et al.  Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. , 2006, American journal of physiology. Endocrinology and metabolism.